Cipla Ltd. — Investor Relations & Filings
Cipla Ltd. is a global pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of generic and branded medicines. The company maintains a diverse portfolio of over 1,500 products across various therapeutic areas, including respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system treatments. It is recognized for its leadership in respiratory care and its historical role in making HIV/AIDS treatment affordable through the introduction of low-cost antiretroviral drugs. Operating with a strong emphasis on research and development, the firm utilizes advanced technology to produce complex generics and drug delivery systems. Its global footprint spans multiple continents, serving healthcare providers and patients in numerous international markets through a robust supply chain and manufacturing infrastructure.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Product launch | 2025-04-11 | English | |
| Board Meeting — Board Meeting Intimation | 2025-04-08 | English | |
| Board Meeting — Financial Results/Dividend | 2025-04-07 | English | |
| Disclosure under SEBI Takeover Regulations | 2025-04-04 | English | |
| ESOP/ESOS/ESPS | 2025-03-19 | English | |
| Updates | 2025-02-20 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 42400871 | Product launch | 2025-04-11 | English | ||
| 43911826 | Board Meeting — Board Meeting Intimation | 2025-04-08 | English | ||
| 43911926 | Board Meeting — Financial Results/Dividend | 2025-04-07 | English | ||
| 42404419 | Disclosure under SEBI Takeover Regulations | 2025-04-04 | English | ||
| 42387887 | ESOP/ESOS/ESPS | 2025-03-19 | English | ||
| 42404558 | Updates | 2025-02-20 | English | ||
| 42404689 | Product launch | 2025-02-20 | English | ||
| 42418881 | General Updates | 2025-02-18 | English | ||
| 42426040 | Investor Presentation | 2025-02-18 | English | ||
| 42414238 | ESOP/ESOS/ESPS | 2025-02-13 | English | ||
| 42522693 | Analysts/Institutional Investor Meet/Con. Call Updates | 2025-02-10 | English | ||
| 42554735 | Updates | 2025-02-08 | English | ||
| 42502898 | General Updates | 2025-02-03 | English | ||
| 42522552 | Analysts/Institutional Investor Meet/Con. Call Updates | 2025-01-31 | English | ||
| 42441212 | Copy of Newspaper Publication | 2025-01-29 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Cipla Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/59275/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=59275 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=59275 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=59275 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 59275}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cipla Ltd. (id: 59275)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.